Media releases

Columvi (glofitamab) will be added to the Cancer Drug List (CDL) and Medication Assistance Fund (MAF) on 1 September 2026 for eligible patients.

For Pharma enquiries, please contact:
Tel: +65 6830 9389
Email: [email protected]

For Diagnostics enquiries, please contact:
Tel: +65 9776 7523
Email: [email protected]

For Technical Operations enquiries, please contact:
Tel: +65 64914000